Huadong Medicine Co Ltd Strategic Asset Allocation Index
Huadong Medicine Co Ltd strategic asset allocation index. Huadong Medicine Co Ltd (000963) has a Strategic Asset Allocation Index of 23.9% as of September 2023. Strategic assets (PP&E of CN¥5.00 Billion plus long-term investments of CN¥-) total CN¥5.00 Billion, measured against net assets of CN¥20.94 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Huadong Medicine Co Ltd to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Huadong Medicine Co Ltd (2000–2022)
Strategic asset allocation index of Huadong Medicine Co Ltd from 2000 to 2022. This chart shows how Huadong Medicine Co Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of September 2023, the index stands at 23.9%, representing strategic assets of CN¥5.00 Billion against net assets of CN¥20.94 Billion CNY.
Huadong Medicine Co Ltd Strategic Asset Allocation Index by Year (2000–2022)
Huadong Medicine Co Ltd strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Huadong Medicine Co Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Huadong Medicine Co Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 26.2% | CN¥5.02 Billion | CN¥5.02 Billion | CN¥- | CN¥19.18 Billion | ▼ -2.2 pp |
| 2021 | 28.4% | CN¥4.81 Billion | CN¥4.81 Billion | CN¥- | CN¥16.94 Billion | ▼ -2.3 pp |
| 2020 | 30.7% | CN¥4.66 Billion | CN¥4.66 Billion | CN¥- | CN¥15.18 Billion | ▼ -0.4 pp |
| 2019 | 31.1% | CN¥4.01 Billion | CN¥4.01 Billion | CN¥- | CN¥12.87 Billion | ▲ +4.0 pp |
| 2018 | 27.2% | CN¥2.83 Billion | CN¥2.65 Billion | CN¥180.03 Million | CN¥10.43 Billion | ▲ +0.5 pp |
| 2017 | 26.6% | CN¥2.34 Billion | CN¥2.18 Billion | CN¥166.02 Million | CN¥8.81 Billion | ▼ -0.7 pp |
| 2016 | 27.3% | CN¥2.09 Billion | CN¥1.93 Billion | CN¥155.67 Million | CN¥7.64 Billion | ▼ -31.2 pp |
| 2015 | 58.5% | CN¥1.90 Billion | CN¥1.75 Billion | CN¥144.49 Million | CN¥3.24 Billion | ▲ +2.0 pp |
| 2014 | 56.5% | CN¥1.42 Billion | CN¥1.42 Billion | CN¥- | CN¥2.52 Billion | ▲ +14.4 pp |
| 2013 | 42.2% | CN¥1.27 Billion | CN¥1.27 Billion | CN¥- | CN¥3.02 Billion | ▼ -0.3 pp |
| 2012 | 42.4% | CN¥993.20 Million | CN¥993.20 Million | CN¥- | CN¥2.34 Billion | ▼ -5.8 pp |
| 2011 | 48.2% | CN¥864.28 Million | CN¥864.28 Million | CN¥- | CN¥1.79 Billion | ▼ -1.8 pp |
| 2010 | 50.0% | CN¥672.73 Million | CN¥672.73 Million | CN¥- | CN¥1.35 Billion | ▲ +13.5 pp |
| 2009 | 36.5% | CN¥471.83 Million | CN¥471.83 Million | CN¥- | CN¥1.29 Billion | ▼ -14.1 pp |
| 2008 | 50.6% | CN¥451.49 Million | CN¥451.49 Million | CN¥- | CN¥892.80 Million | ▲ +3.8 pp |
| 2007 | 46.7% | CN¥319.84 Million | CN¥319.84 Million | CN¥- | CN¥684.27 Million | ▲ +0.7 pp |
| 2006 | 46.0% | CN¥335.16 Million | CN¥335.16 Million | CN¥- | CN¥728.30 Million | ▼ -0.6 pp |
| 2005 | 46.6% | CN¥320.37 Million | CN¥320.37 Million | CN¥- | CN¥686.99 Million | ▼ -0.7 pp |
| 2004 | 47.3% | CN¥307.15 Million | CN¥307.15 Million | CN¥- | CN¥648.91 Million | ▲ +6.0 pp |
| 2003 | 41.3% | CN¥263.51 Million | CN¥263.51 Million | CN¥- | CN¥637.95 Million | ▲ +1.3 pp |
| 2002 | 40.0% | CN¥243.02 Million | CN¥243.02 Million | CN¥- | CN¥607.81 Million | ▲ +12.8 pp |
| 2001 | 27.2% | CN¥157.34 Million | CN¥157.34 Million | CN¥- | CN¥578.05 Million | ▲ +1.1 pp |
| 2000 | 26.2% | CN¥135.09 Million | CN¥135.09 Million | CN¥- | CN¥516.34 Million | — |